Our approach and experience enables us to identify and engage often difficult to locate specialists and patients to share their insight and opinions.
We always aim to use moderators with extensive experience in the therapy area involved and the list below gives a flavour of some of the orphan diseases we have undertaken qualitative research studies in over the years.
Orphan Disease Expertise
Click the cross: Orphan Diseases recently researched
|ADPKD – Autosomal Dominant Polycystic Kidney Disease|
|ALL – Acute Lymphoblastic Leukaemia|
|ALS – Amyotrophic Lateral Sclerosis|
|AML – Acute Myeloid Leukemia|
|B-CLL – B-cell Chronic Lymphocytic Leukemia|
|B-NHL – B-cell Non-Hodgkin Lymphoma|
|BP – Bullous Pemphigoid|
|CF – Cystic Fibrosis|
|CHL – Classical Hodgkin Lymphoma|
|CHM – Choroideremia|
|CIDP – Chronic Inflammatory Demyelinating Polyneuropathy|
|CMV – Cytomegalovirus Disease|
|Cold Agglutinin Disease|
|DEB – Dystrophic Epidermolysis Bullosa|
|DMD – Duchenne Muscular Dystrophy|
|FAP – Familial Amyloid Polyneuropathy|
|GBM – Glioblastoma|
|HAE – Hereditary Angioedema|
|Homozygous Familial Hypercholesterolemia|
|ITP – Immune Thrombocytopenic Purpura|
|MS – Multiple Sclerosis|
|NASH – Nonalcoholic Steatohepatitis|
|NHL – Non-Hodgkin Lymphoma|
|NMO – Neuromyelitis Optica|
|PBC – Primary Biliary Cirrhosis (Hanet Syndrome)|
|PNH – Paroxysmal Nocturnal Hemoglobinuria|
|PV – Polycythemia Vera|
|RCC – Renal Cell Carcinoma|
|San Filippo A|
|Sickle Cell Disease|
|SSc – Systemic Sclerosis|
|VWD – Von Willebrand Disease|
Find Out More
Alternatively, download the list of orphan diseases already researched by KQH or contact us for more information.
In search of Hunter’s Disease specialists
A boutique consulting firm needed to gather feedback from named specialists in the treatment of Hunter’s disease for a study they were conducting. This was a very high profile study for our client and they were keen to maximise on the number of respondents involved in the study.
Drawing on a list provided by the client, we contacted haematologists, paediatric neuro specialists and geneticists across 13 countries. Our experienced recruiters ensured 1 in 4 specialists approached agreed to take part in the research.
Our client went on to win a long-term contract in this disease area and we have subsequently been called in to help them recruit Hunter’s Disease patients in South Korea in a follow-up study (there are only 72 patients in all of South Korea and we recruited 10 of these). This has also led to a further three waves of the original research being conducted across the 13 countries.